16 Risk of nutrient deficiencies: GLP-1 agonists significantly reduce appetite, gastrointestinal motility, and nutrient absorption, leading to reduced calorie and protein intake
doi:10.1001/jama.2024.10816 Fredrick TW, Camilleri M, Acosta A
Products marketed as natural GLP-1 boosters do not contain GLP-1 or a GLP-1 agonist, and physicians are openly skeptical that they replicate the medication's effects
Side effects of MK-677 include pronounced appetite increase, more significant water retention than ipamorelin, and notable effects on blood sugar and insulin sensitivity
National Library of Medicine, National Institutes of Health, U.S